<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04576806</url>
  </required_header>
  <id_info>
    <org_study_id>EPN 2019-05492</org_study_id>
    <nct_id>NCT04576806</nct_id>
  </id_info>
  <brief_title>Physiological Effects of 38째C vs. 22째C Fluid Therapy in Critically Ill Patients</brief_title>
  <official_title>Physiological Effects of 38째C vs. 22째C Fluid Therapy in Critically Ill Patients: A Randomized Controlled ICU Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danderyd Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stockholm South General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled clinical trial. 24 adult ICU patients will be recruited upon decision&#xD;
      to administer fluid bolus of 500ml of crystalloid. The fluid will then be randomized to be&#xD;
      infused at controlled room temperature or warmed to body temperature. Hemodynamic&#xD;
      measurements will be made for 2 hours following the bolus, and laboratory values will be&#xD;
      noted. The hypothesis is that part of the hemodynamic response will differed in response to&#xD;
      cooling, and be larger in the cold group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled clinical trial of the influence of fluid temperature on hemodynamic&#xD;
      effects of fluids. 24 adult ICU patients meeting objective criteria of circulatory impairment&#xD;
      (hypotension, tachycardia, lactatemia etc) will be recruited upon decision to administer&#xD;
      fluid bolus of 500ml of crystalloid. The fluid will then be randomized to be infused at&#xD;
      controlled room temperature of 22 degrees or warmed to body temperature at 38 degrees. All&#xD;
      patients will be monitored with either calibrated or uncalibrated pulse contour analysis.&#xD;
      Hemodynamic measurements (Heart rate (HR), Systolic blood pressure (SBP), Diastolic blood&#xD;
      pressure (DBP), Mean arterial pressure (MAP), Cardiac output (CO), Cardiac index (CI), Stroke&#xD;
      volume (SV), Stroke volume variation (SVV), Extravascular lung water (EVLW) etc) will be&#xD;
      registered for 2 hours following the bolus, and laboratory values such as lactate, creatinine&#xD;
      will be noted, as well as fluid balances. Confounders such as levels of vasopressors,&#xD;
      sedation, switches in positioning och or ventilation will be registered. The hypothesis is&#xD;
      that part of the hemodynamic response will differed in response to cooling, and be larger in&#xD;
      the cold group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2021</start_date>
  <completion_date type="Anticipated">October 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>RCT, unblinded</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Investigators will be blinded during analysis but unblinded during study performance.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>MAP</measure>
    <time_frame>15 minutes</time_frame>
    <description>Mean arterial pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MAP</measure>
    <time_frame>1 hour</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MAP</measure>
    <time_frame>2 hours</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>15 minutes</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>1 hour</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SBP</measure>
    <time_frame>2 hours</time_frame>
    <description>Systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>15 minutes</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>1 hour</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DBP</measure>
    <time_frame>2 hours</time_frame>
    <description>Diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>15 minutes</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>1 hour</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>2 hours</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CO</measure>
    <time_frame>15 minutes</time_frame>
    <description>Cardiac output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CO</measure>
    <time_frame>1 hour</time_frame>
    <description>Cardiac output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CO</measure>
    <time_frame>2 hours</time_frame>
    <description>Cardiac output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CI</measure>
    <time_frame>15 minutes</time_frame>
    <description>Cardiac index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CI</measure>
    <time_frame>1 hour</time_frame>
    <description>Cardiac index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CI</measure>
    <time_frame>2 hours</time_frame>
    <description>Cardiac index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SV</measure>
    <time_frame>15 minutes</time_frame>
    <description>Stroke volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SV</measure>
    <time_frame>1 hour</time_frame>
    <description>Stroke volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SV</measure>
    <time_frame>2 hours</time_frame>
    <description>Stroke volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SVV</measure>
    <time_frame>15 minutes</time_frame>
    <description>Stroke volume variation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SVV</measure>
    <time_frame>1 hour</time_frame>
    <description>Stroke volume variation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SVV</measure>
    <time_frame>2 hours</time_frame>
    <description>Stroke volume variation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EVLW</measure>
    <time_frame>15 minutes</time_frame>
    <description>Extra vascular lung water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EVLW</measure>
    <time_frame>1 hour</time_frame>
    <description>Extra vascular lung water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EVLW</measure>
    <time_frame>2 hours</time_frame>
    <description>Extra vascular lung water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type ofh eart rhythm</measure>
    <time_frame>15 minutes</time_frame>
    <description>Heart rhythm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of heart rhythm</measure>
    <time_frame>1 hour</time_frame>
    <description>Heart rhythm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of heart rhythm</measure>
    <time_frame>2 hours</time_frame>
    <description>Heart rhythm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of administered vasopressors</measure>
    <time_frame>15 minutes</time_frame>
    <description>Amount of pressors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of administered vasopressors</measure>
    <time_frame>1 hours</time_frame>
    <description>Amount of pressors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of administered vasopressors</measure>
    <time_frame>2 hours</time_frame>
    <description>Amount of pressors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of administered sedating medications</measure>
    <time_frame>15 minutes</time_frame>
    <description>Amount of sedation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of administered sedating medications</measure>
    <time_frame>1 hours</time_frame>
    <description>Amount of sedation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of administered sedating medications</measure>
    <time_frame>2 hours</time_frame>
    <description>Amount of sedation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactate</measure>
    <time_frame>15 minutes</time_frame>
    <description>Lactate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of lactate</measure>
    <time_frame>1 hour</time_frame>
    <description>Lactate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of lactate</measure>
    <time_frame>2 hours</time_frame>
    <description>Lactate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hourly urine output</measure>
    <time_frame>1 hour</time_frame>
    <description>Urine output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hourly urine output</measure>
    <time_frame>2 hours</time_frame>
    <description>Urine output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temperature change</measure>
    <time_frame>15 minutes</time_frame>
    <description>Temperature change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temperature change</measure>
    <time_frame>1 hour</time_frame>
    <description>Temperature change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temperature change</measure>
    <time_frame>2 hours</time_frame>
    <description>Temperature change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily fluid balance</measure>
    <time_frame>24 hours</time_frame>
    <description>Fluid balance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily fluid balance</measure>
    <time_frame>48 hours</time_frame>
    <description>Fluid balance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Critical Illness</condition>
  <condition>Sepsis</condition>
  <condition>Fluid Overload</condition>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>Body temperature fluid bolus of crystalloid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluid bolus at 38 degrees celsius of 500ml crystalloid over 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Room temperature fluid bolus of crystalloid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluid bolus at 22 degrees celsius of 500ml crystalloid over 15 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Body temperature</intervention_name>
    <description>Warming of administered fluid bolus</description>
    <arm_group_label>Body temperature fluid bolus of crystalloid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluid bolus</intervention_name>
    <description>Administration of fluid bolus of crystalloid of 500ml over 15 minutes</description>
    <arm_group_label>Body temperature fluid bolus of crystalloid</arm_group_label>
    <arm_group_label>Room temperature fluid bolus of crystalloid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Room temperature</intervention_name>
    <description>Cooling of administered fluid bolus</description>
    <arm_group_label>Room temperature fluid bolus of crystalloid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admission to the ICU&#xD;
&#xD;
          -  Age 18 years or older&#xD;
&#xD;
          -  Clinical decision to administer a fluid bolus of at least 500 ml of crystalloid over&#xD;
             15 minutes.&#xD;
&#xD;
          -  Monitoring with either an arterial line in an extremity that can be used for pulse&#xD;
             contour analysis (Vigileo, FloTrac or equivalent system) or a central venous catheter&#xD;
             and a femoral arterial line that can be used for pulse contour analysis calibrated by&#xD;
             thermodilution (EV1000, PiCCO or equivalent system)&#xD;
&#xD;
          -  At least one of the following criteria for fluid administration must be met:&#xD;
&#xD;
          -  MAP &lt; 65 mmHg&#xD;
&#xD;
          -  HR &gt;100&#xD;
&#xD;
          -  Urine output &lt; 0,5ml/kg/h&#xD;
&#xD;
          -  Lactate levels of &gt; 3 mmol/l&#xD;
&#xD;
          -  CI &lt; 2.5L/min/m2&#xD;
&#xD;
          -  SVV or PPV &gt; 12% if mechanically ventilated with tidal volumes &gt; 7 ml/kg&#xD;
&#xD;
          -  ScvO2 or SvO2 &lt; 65%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active bleeding requiring transfusion&#xD;
&#xD;
          -  Haemoglobin level &lt;70 g/L&#xD;
&#xD;
          -  Arrhythmia disturbing monitoring of cardiac output&#xD;
&#xD;
          -  Patients in whom death is considered imminent (within 24 hours)&#xD;
&#xD;
          -  CRRT&#xD;
&#xD;
          -  Known pregnancy&#xD;
&#xD;
          -  Active temperature control, either active warming or cooling&#xD;
&#xD;
          -  Medical issue of pathological thermoregulation, such as malignant hyperthermia,&#xD;
             thyroid storm, NMDA overdose, serotonin syndrome, malignant neuroleptic syndrome, or&#xD;
             delirium.&#xD;
&#xD;
          -  Planned exit from the ICU during the 2-hour monitoring period (planned surgical&#xD;
             procedure, radiology, change of department etc.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Cronhjort, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>maria.cronhjort@ki.se</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olof Wall, MD</last_name>
    <phone>0736163034</phone>
    <email>olof.wall@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Cronhjort, MD, PhD</last_name>
    <phone>0735671555</phone>
    <email>maria.cronhjort@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>S철dersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <zip>118 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Maria Cronhjort, MD, PhD</last_name>
      <email>maria.cronhjort@ki.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Danderyds sjukhus</name>
      <address>
        <city>Stockholm</city>
        <zip>182 57</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Olof Wall, MD</last_name>
      <phone>0736163034</phone>
      <email>olof.wall@ki.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 23, 2020</study_first_submitted>
  <study_first_submitted_qc>September 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2020</study_first_posted>
  <last_update_submitted>September 29, 2020</last_update_submitted>
  <last_update_submitted_qc>September 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Christer Svensen</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Fluid therapy</keyword>
  <keyword>Bolus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No data will be shared outside the research group</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

